The largest study to date evaluating late neurological events after transcatheter aortic valve replacement (TAVR) has shown an increased rate of stroke and a very high rate of associated mortality in ...

Patients who suffer a stroke during hospitalization for infective endocarditis (IE) after transcatheter aortic valve replacement (TAVR) have a dismal prognosis, with more than half dying during the ...

I was one of the estimated 2.5 million Americans over the age of 75 with aortic stenosis, or AS, a hardening and narrowing of the aortic valve -- the primary valve that helps deliver blood through the ...

Please provide your email address to receive an email when new articles are posted on . In patients having TAVR, cerebral embolic protection reduced risk for periprocedural stroke in patients from the ...

Stroke remains a problem after TAVR and continues to feed discussions around how extensively cerebral embolic protection devices and other strategies should be used. In a session during TVT Connect, ...

Please provide your email address to receive an email when new articles are posted on . A single-center study suggests prior stroke and initial experience are independent risk factors for stroke ...

Five-year data from the PARTNER 3 trial showed that among low-risk patients with severe, symptomatic aortic stenosis, ...

A recent study found patients who undergo transcatheter aortic valve replacement have higher risk of stroke for up to two years after the procedure. The study, published in the December issue of JACC: ...

(UPDATED) Full results of the secondary analysis looking at neurological events in the SURTAVI trial affirm that intermediate-risk patients who underwent TAVR with the self-expanding CoreValve ...

New analysis from the EARLY TAVR trial showed patients between the age of 65 and 70 years old derived the most benefits of a strategy of early intervention with transcatheter aortic valve replacement ...

A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the ...